Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Donna M WilcockDave Morgan

Abstract

The role of microglia in the removal of amyloid deposits after systemically administered anti-Abeta antibodies remains unclear. In the current study, we injected Tg2576 APP transgenic mice weekly with an anti-Abeta antibody for 1, 2, or 3 months such that all mice were 22 months at the end of the study. In mice immunized for 3 months, we found an improvement in alternation performance in the Y maze. Histologically, we were able to detect mouse IgG bound to congophilic amyloid deposits in those mice treated with the anti-Abeta antibody but not in those treated with a control antibody. We found that Fcgamma receptor expression on microglia was increased after 1 month of treatment, whereas CD45 was increased after 2 months of treatment. Associated with these microglial changes was a reduction in both diffuse and compact amyloid deposits after 2 months of treatment. Interestingly, the microglia markers were reduced to control levels after 3 months of treatment, whereas amyloid levels remained reduced. Serum Abeta levels and anti-Abeta antibody levels were elevated to similar levels at all three survival times in mice given anti-Abeta injections rather than control antibody injections. These data show that the antibody is able to en...Continue Reading

Citations

Jul 9, 2008·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Rachel A KarlnoskiDave Morgan
Oct 24, 2008·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Dave MorganPaula Bickford
Dec 5, 2008·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Sriram VennetiJulia Kofler
Jan 13, 2010·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Qing-you LiDave Morgan
Dec 27, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Qingyou LiMarcia N Gordon
Dec 17, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Sarah B MatousekM Kerry O'Banion
Jul 25, 2009·Molecular Neurobiology·Marina A Lynch
Mar 3, 2010·Molecular Neurobiology·Lih-Fen LueDouglas G Walker
Jun 27, 2013·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Sarah K Kaufman, Marc I Diamond
Jul 16, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Roger M Nitsch, Christoph Hock
Dec 15, 2010·Molecular Pharmaceutics·Qing-Hui ZhouWilliam M Pardridge
Sep 29, 2011·Nature Neuroscience·Marco PrinzRichard M Ransohoff
Oct 13, 2006·Nature Reviews. Neuroscience·Amir Rattner, Jeremy Nathans
Feb 28, 2009·Proceedings of the National Academy of Sciences of the United States of America·Deepak R ThakkerLisa L Shafer
Jun 22, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jin-Dong DingCatherine Bowes Rickman
Nov 30, 2006·DNA and Cell Biology·Anahit GhochikyanDavid H Cribbs
Apr 3, 2010·Brain : a Journal of Neurology·Alberto Serrano-PozoBradley T Hyman
Aug 15, 2013·Brain : a Journal of Neurology·Elina ZotovaDelphine Boche
Jun 9, 2005·Alzheimer Disease and Associated Disorders·John C Morris
Jun 15, 2006·Alzheimer Disease and Associated Disorders·Robert P Brendza, David M Holtzman
Mar 29, 2012·Current Gerontology and Geriatrics Research·Donna M Wilcock
Jul 31, 2012·International Journal of Alzheimer's Disease·Donna M Wilcock
Feb 1, 2012·International Journal of Alzheimer's Disease·Kasia LobelloRonald Black
Aug 16, 2006·Neuro-degenerative Diseases·M Hasan MohajeriRoger M Nitsch
Aug 16, 2006·Neuro-degenerative Diseases·Dave Morgan
Feb 1, 2005·Immunity & Ageing : I & a·Marc E Weksler
Feb 4, 2010·Alzheimer's Research & Therapy·Elina ZotovaDelphine Boche
Jun 7, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Tiffany L SudduthDonna M Wilcock
Jun 26, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Donna M WilcockCarol A Colton
Dec 26, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jessica Koenigsknecht-TalbooDavid M Holtzman
Apr 18, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Tristan BolmontMichael E Calhoun
Feb 15, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Donna M WilcockCarol A Colton
Mar 18, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Allan WangJoanna L Jankowsky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.